GT Biopharma, Inc.
$0.29
+0.00 (+1.01%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -6.4%
- 3 Months
- -38.2%
- YTD
- -63.2%
- 1 Year
- -69.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 122.3%
- Largest decline max drawdown, since Aug 2025
- -81.7%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.36
Own GTBP?
See how GTBP contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.